Terms: = Pancreatic cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
42 results:
1. Nuclear MAST4 Suppresses foxo3 through Interaction with AKT3 and Induces Chemoresistance in pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
2. foxo3a functions as a transcriptional and co-transcriptional splicing regulator in vascular endothelial cell lines.
Abudureyimu S; He C; Xie W; Chen Z; Airikenjiang H; Abulaiti D; Cao Y; Qiu H; Gao Y
Gene; 2024 Apr; 904():148221. PubMed ID: 38286271
[TBL] [Abstract] [Full Text] [Related]
3. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH; Al-Hallak MN; Khan HY; Aboukameel A; Li Y; Bannoura SF; Dyson G; Kim S; Mzannar Y; Azar I; Odisho T; Mohamed A; Landesman Y; Kim S; Beydoun R; Mohammad RM; Philip PA; Shields AF; Azmi AS
Clin Transl Med; 2023 Dec; 13(12):e1513. PubMed ID: 38131168
[TBL] [Abstract] [Full Text] [Related]
4. Prolyl isomerase Pin1 promotes autophagy and cancer cell viability through activating foxo3 signalling.
Long J; Wang J; Dong Y; Yang J; Xie G; Tong Y
Cell Signal; 2024 Jan; 113():110940. PubMed ID: 38084839
[TBL] [Abstract] [Full Text] [Related]
5. ATIC inhibits autophagy in hepatocellular cancer through the AKT/foxo3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
6. LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/foxo3/BID axis to inhibit the progression of pancreatic cancer.
Bi C; Wang G
J Cell Mol Med; 2021 Sep; 25(17):8312-8328. PubMed ID: 34363438
[TBL] [Abstract] [Full Text] [Related]
7. Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells.
Warkad MS; Kim CH; Kang BG; Park SH; Jung JS; Feng JH; Inci G; Kim SC; Suh HW; Lim SS; Lee JY
Sci Rep; 2021 Jul; 11(1):14002. PubMed ID: 34234193
[TBL] [Abstract] [Full Text] [Related]
8. SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis.
Leng S; Huang W; Chen Y; Yang Y; Feng D; Liu W; Gao T; Ren Y; Huo M; Zhang J; Yang Y; Wang Y
Cell Death Differ; 2021 Dec; 28(12):3329-3343. PubMed ID: 34163012
[TBL] [Abstract] [Full Text] [Related]
9. pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract] [Full Text] [Related]
10. Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a foxo3/miRNA-30b-5p/MINPP1 axis.
Chen W; Jiang J; Gong L; Shu Z; Xiang D; Zhang X; Bi K; Diao H
J Exp Clin Cancer Res; 2021 Jan; 40(1):1. PubMed ID: 33390177
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).
Puccini A; Poorman K; Salem ME; Soldato D; Seeber A; Goldberg RM; Shields AF; Xiu J; Battaglin F; Berger MD; Tokunaga R; Naseem M; Barzi A; Iqbal S; Zhang W; Soni S; Hwang JJ; Philip PA; Sciallero S; Korn WM; Marshall JL; Lenz HJ
Clin Cancer Res; 2020 Nov; 26(22):5943-5951. PubMed ID: 32883742
[TBL] [Abstract] [Full Text] [Related]
12. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/foxo3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract] [Full Text] [Related]
13. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
14. foxo3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in pancreatic cancer Cells.
Usami M; Kikuchi S; Takada K; Ono M; Sugama Y; Arihara Y; Hayasaka N; Nakamura H; Ikeda Y; Hirakawa M; Yoshida M; Miyanishi K; Kobune M; Kato J
Pancreas; 2020 Jan; 49(1):135-142. PubMed ID: 31856089
[TBL] [Abstract] [Full Text] [Related]
15. miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting foxo3a and reverses chemoresistance in hepatocellular carcinoma cells.
Zhou Y; Chen E; Tang Y; Mao J; Shen J; Zheng X; Xie S; Zhang S; Wu Y; Liu H; Zhi X; Ma T; Ni H; Chen J; Chai K; Chen W
Cell Death Dis; 2019 Nov; 10(11):843. PubMed ID: 31695022
[TBL] [Abstract] [Full Text] [Related]
16. MiR-223 regulates CDDP resistance in pancreatic cancer via targeting foxo3a.
Huang R; Song X; Wang CM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7892-7898. PubMed ID: 31599414
[TBL] [Abstract] [Full Text] [Related]
17. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/foxo3a pathways.
Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
[TBL] [Abstract] [Full Text] [Related]
18. Expression of the PTEN/foxo3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression.
Zhang Q; Li X; Li Y; Chen S; Shen X; Dong X; Song Y; Zhang X; Huang K
Invest New Drugs; 2020 Apr; 38(2):321-328. PubMed ID: 31087222
[TBL] [Abstract] [Full Text] [Related]
19. TRPM2 in cancer.
Miller BA
Cell Calcium; 2019 Jun; 80():8-17. PubMed ID: 30925291
[TBL] [Abstract] [Full Text] [Related]
20. MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway.
Wang T; Chen G; Ma X; Yang Y; Chen Y; Peng Y; Bai Z; Zhang Z; Pei H; Guo W
Cell Death Dis; 2019 Feb; 10(3):153. PubMed ID: 30770779
[TBL] [Abstract] [Full Text] [Related]
[Next]
